Oppenheimer Holdings Inc. started coverage on shares of TherapeuticsMD Inc (AMEX:TXMD) in a research report released on Tuesday morning, StockTargetPrices.com reports. The brokerage issued an outperform rating on the stock.
TherapeuticsMD (AMEX:TXMD) opened at 7.10 on Tuesday. TherapeuticsMD has a 52 week low of $4.39 and a 52 week high of $11.26. The company’s 50 day moving average is $6.27 and its 200 day moving average is $7.34. The stock’s market cap is $1.40 billion.